Balloon dilation catheters have been used extensively for percutaneous transluminal dilation of vascular narrowings. A recent urological application has been the use of a balloon to dilate acutely the normal ureteral orifice and intramural ureter for the purpose of performing transurethral ureteroscopy. Complications of balloon dilation may result if over inflation and bursting of the balloon occur followed by ureteral injury. We report the pressure needed to dilate the ureter adequately in 122 patients during an 18-month period. Adequate dilation was achieved in 93 patients (78 per cent) at pressures of 8 atmospheres or less, while 27 (22 per cent) required more than 10 atmospheres of pressure. Balloon dilation was not satisfactory in 2 patients (2 per cent) but it was accomplished by metal bougies. Our results confirm the safety and efficiency of balloon dilation to facilitate ureteroscopy. Important safeguards when using this method include the use of balloons designed specifically for ureteral dilation, slow balloon inflation to allow for ureteral accommodation and the use of fluoroscopy to judge the end point of dilation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0022-5347(17)41896-9 | DOI Listing |
World J Urol
March 2025
Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, China.
Heart Vessels
March 2025
Department of Burn and Wound Repair Center, Hebei Medical University Third Hospital, No. 139 Ziqiang Rd, Shijiazhuang, 050000, Hebei, China.
We introduce a technique for treating chronic limb-threatening ischemia with superficial femoral artery flush occlusion, facilitating intravascular treatment when conventional anterograde puncture is challenging. This retrospective study reviewed 37 patients who underwent vascular sheath fenestration assisted anterograde puncture to complete endovascular treatment for chronic limb-threatening ischemia from December 2022 to December 2023. All patients had superficial femoral artery flush occlusion, meeting chronic limb-threatening ischemia diagnostic criteria.
View Article and Find Full Text PDFNat Rev Dis Primers
March 2025
Center for Outcome Research in Liver Diseases, Washington, DC, USA.
Primary sclerosing cholangitis (PSC) is a chronic biliary inflammation associated with periductular fibrosis of the intrahepatic and extrahepatic bile ducts leading to strictures, bacterial cholangitis, decompensated liver disease and need for liver transplantation. This rare focal liver disease affects all races and ages, with a predominance of young males. There is an up to 88% association with inflammatory bowel disease.
View Article and Find Full Text PDFRev Med Liege
March 2025
Service de Gastro-entérologie, Hépatologie et Oncologie digestive, CHU Liège, Belgique.
Crohn's disease is a chronic inflammatory bowel disease that can lead to fibrostenotic complications. These strictures result from an imbalance between inflammation and excessive healing, leading to an abnormal accumulation of extracellular matrix and a progressive thickening of the intestinal wall. To date, no specific treatment is available to prevent or reverse intestinal fibrosis.
View Article and Find Full Text PDFCardiovasc Revasc Med
March 2025
Department of Cardiology, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark.
Background: Lumen reduction after bioresorbable scaffold implantation has been reported. This study aimed to assess the influence of pre-dilatation with a scoring balloon versus a standard non-compliant balloon prior to implanting a magnesium-based Magmaris bioresorbable scaffold (MgBRS) on lumen measurements using optical coherence tomography (OCT) and on clinical outcomes after 12 months.
Method: In the OPTIMIS-study (Optimal lesion preparation before implantation of a MgBRS in patients with coronary artery stenosis), patients were randomly assigned to pre-dilatation with a scoring balloon or a standard non-compliant balloon before MgBRS implantation.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!